
Venture funds are becoming a more common offering at universities around the world. Why do a majority of the top US institutions not have one?
Academics who become entrepreneurs face not just a learning curve, but a mindset shift.
Universities in Australia and New Zealand typically take a higher portion of ownership in spinout companies. Founders are calling for more standardised deal terms.
Here are three options that help corporates link up with universities and research labs to tackle research and development hurdles.
Academic institutions are taking new approaches to transferring intellectual property rights of university research in a bid to help spinouts attract investors.
A new $35m fund will be managed by external venture studio High Alpha Innovation and will work with the university on creating new startups.
From a chest-worn device to help with Parkinson's symptoms to stress measuring socks — here are the spinouts providing support for senior citizens.
Basel has quietly built a life sciences ecosystem that’s becoming hard to ignore.
What if living to 100 was the norm rather than the exception for humans? Here are 10 companies using university research to make it happen.
From healthcare to fusion to quantum computing to space, superconductors have the potential to revolutionise the world. And the technology is finally ready to commercialise.
Startups often find the UK's National Health Service hard to sell into. These three tips can stop founders falling at the first hurdle.
Sustainable energy means a more efficient grid and better storage. These breakthrough spinouts have ideas on how to do it.
From needleless wearables that monitor glucose to thermal imaging that prevents amputations, spinouts are improving care for a disease that affects 550m people.
From carbon-negative lithium to quickly assessing the safety of mines, here are seven university spinouts that could transform the mining industry.
The VC firm is raising money from investors for its second UK spinout fund.
The British Business Bank plans to invest in university spinout investment funds outside of the Golden Triangle.
The federal cuts to science and research funding mean US universities are leaning more on spinout funds and tech transfer offices to generate income.
Funders are increasingly making global access to healthcare IP a condition of their grants.
Professors have academic teaching obligations that can distract them from leading a spinout, but their technical expertise is also often invaluable to its commercial success.
Pooling tech transfer resources could help smaller universities commercialise technology that they can't push out on their own.